ATR inhibition using gartisertib enhances cell death and synergises with temozolomide and radiation in patient-derived glioblastoma cell lines
M. Lozinski, N. A. Bowden, M. C. Graves, M. Fay, B. W. Day, B. W. Stringer, P. A. Tooney
This study shows that ATR inhibition with gartisertib enhances cell death and synergizes with TMZ and RT in glioblastoma cell lines, particularly in TMZ-resistant cells.
bioRxiv · Nov 2, 2023Cancer Biology